Fibroblast growth factor 15 (Fgf15) is expressed in the developing mouse central nervous system and pharyngeal arches. Fgf15 mutant mice showed defects of the cardiac outflow tract probably because of aberrant behavior of the cardiac neural crest cells. In this study, we examined cis-elements of the Fgf15 gene by transient transgenic analysis using lacZ as a reporter. We identified two enhancers: one directed lacZ expression in the hindbrain/spinal cord and the other in the posterior midbrain (pmb), rhombomere1 (r1) and pharyngeal epithelia. Interestingly, human genomic regions which are highly homologous to these two mouse enhancers showed almost the same enhancer activities as those of mice in transgenic mouse embryos, indicating that the two enhancers are conserved between humans and mice. We also showed that the mouse and human pmb/r1 enhancer can regulate lacZ expression in chick embryos in almost the same way as in mouse embryos. We found that the lacZ expression domain with this enhancer was expanded by ectopic Fgf8b expression, suggesting that this enhancer is regulated by Fgf8 signaling. Moreover, over-expression of Fgf15 resulted in up-regulation of Fgf8 expression in the isthmus/r1. These findings suggest that a reciprocal positive regulation exists between Fgf15 and Fgf8 in the isthmus/r1. Together with cardiac outflow tract defects in Fgf15 mutants, the conservation of enhancers in the hindbrain/spinal cord and pharyngeal epithelia suggests that human FGF19 (ortholog of Fgf15) is involved in early development and the distribution of cardiac neural crest cells and is one of the candidate genes for congenital heart defects.
Introduction
A number of animal models have significantly promoted our understanding on pathogenesis and genetic basis of human birth defects. One of the most frequently used animal species is mice because we can manipulate their genetic code in order to elucidate the molecular mechanisms how organs develop and how disruption of genes leads to developmental defects. Although it is unlikely that single gene defects account for the majority of human birth defects, mutant mouse models have efficiently proven their value for identifying candidate genes for further investigations in human molecular epidemiologic studies (Cabrera et al., 2004) . During development, expression of genes has to be precisely regulated in spatially and temporally coordinated manners to exert their proper functions. However, it is not certain whether human homologous genes are expressed in similar patterns to mouse genes because human embryo specimens during organogenesis are rarely available. One way to solve this problem is to compare the cis-regulatory elements between human and mouse genomes.
Mouse Fgf15 was first identified as a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1 (McWhirter et al., 1997) . Fgf15 is expressed in the developing mouse central nervous system and is transiently expressed in pharyngeal arches (McWhirter et al., 1997; Gimeno et al., 2003; Wright et al., 2004; Vincentz et al., 2005) . Human FGF19 is considered as a human ortholog of mouse Fgf15. Based on comparative genomics, the human FGF19 and the mouse Fgf15 genes occupy similar positions within a syntenic locus, including FADD/Fadd, FGF3/Fgf3, FGF4/Fgf4, and CCND1/Ccnd1, which are located on chromosomes 11q13.3 and 7F5, respectively (Katoh, 2002; Katoh, 2003; Itoh and Ornitz, 2004; Wright et al., 2004) . In addition, mouse FGF15, like human FGF19, is sufficient to induce expression of otic markers in a chick explant assay, supporting that these FGFs are orthologs (Ladher et al., 2000; Wright et al., 2004) . Human FGF19 is expressed at least in the brain during the fetal period (Nishimura et al., 1999) . We previously reported that Fgf15 expression in the brain is directly initiated by Shh signaling, and subsequently Fgf15 modulates competence of dorsal neural precursors to respond to Wnt mitogens (Ishibashi and McMahon, 2002; Saitsu et al., 2005) . Analysis of Fgf15 mutant mice indicated that Fgf15 is required for perinatal viability and the development of the cardiac outflow tract. Fgf15 mutant mice display defects in outflow tract alignment, and correlate these alignment defects with early morphogenetic defects of the outflow tract attributable to abnormalities of cardiac neural crest cell behavior . Cardiac neural crests migrate from the cranial neural folds between the midotic placode and the caudal limit of somite 3, and have been shown to be necessary for proper outflow tract septation, cardiac innervation, aortic arch re-patterning, and myocardial function (Kirby et al., 1983; Hutson and Kirby, 2003; Martinsen, 2005) . Studies performed in the chick and mouse suggest that complex tissue-tissue interactions between the pharyngeal epithelia, the cardiac neural crests and the secondary heart field, splanchnic mesoderm derived cells moving to augment and lengthen the myocardium of the outflow tract, are crucial for the outflow tract and aortic arch development (Hutson and Kirby, 2003) . Therefore, Fgf15 expression in the dorsal hindbrain/spinal cord and the pharyngeal epithelia seems to be essential for exerting its role in development of the mouse cardiac outflow tract.
In this study, we identified two enhancers of mouse Fgf15 gene by transient transgenic analyses. By using genome bioinformatics, we found that the sequences of these two enhancers are highly conserved among mammalian species. Notably, human genomic regions which are highly homologous to these two mouse enhancers showed similar enhancer activities to those of mice in transgenic mouse embryos. These enhancers were shown to regulate the expression in the hindbrain/spinal cord and in pharyngeal epithelia, both of which are closely related to cardiac outflow tract development. These findings suggest that human FGF19 is expressed in a similar pattern to mouse Fgf15 in the hindbrain/spinal cord and pharyngeal epithelia, and is involved in development of the cardiac outflow tract.
Results
2.1. Identification of two mouse Fgf15 enhancers; I. The optic vesicle, hindbrain, and dorsal spinal cord, II. The posterior midbrain/rhombomere1 and pharyngeal epithelia Previously we reported that the 12 and 3.6 kb fragments upstream of the Fgf15 transcription initiation site (McWhirter et al., 1997) directs reporter expression in a similar pattern to the endogenous Fgf15 gene in the diencephalon, midbrain, hindbrain, and spinal cord at embryonic day 8.5 (E8.5) (Saitsu et al., 2005) . We further investigated its enhancer activities at E9.5 by transient transgenic analysis using lacZ as a reporter. Twelve and eight kilobase 5 0 -flanking regions of the Fgf15 gene (Fig. 1, RC1 and 2, respectively) showed enhancer activities in the hindbrain with intense expression in the rhombomere1 (r1), dorsal spinal cord, pharyngeal ectoderm and endoderm from arch II to presumptive arch IV, and optic vesicle, and a weak activity was found in the posterior midbrain (pmb) (Fig. 2B-B 00 ). These 12 and 8 kb flanking regions did not show significant enhancer activities in the telencephalon, anterior midbrain, and posterior neural tube including tail bud ( Fig. 2A and B ). In the dorsal Fig. 1 . Characterization of mouse Fgf15 regulatory regions in transgenic embryos. Depicted at top is a genomic map surrounding approximately 20 kb of the Fgf15 locus, including the transcriptional units (boxes) and its direction (an arrow) and a partial list of restriction enzyme sites (E, EcoRI; H, HindIII; N, NsiI; S, SphI; Sp, SpeI; Xh, XhoI) used in the generation of the reporter constructs. The green, purple boxes below represent the location of the identified enhancers; green, the optic vesicle, hindbrain (except for r1), and spinal cord enhancer; purple, posterior midbrain/ rhombomere1 and pharyngeal epithelia enhancer. Listed below are reporter constructs (RC) 1-8, which were tested for reporter activity in transgenic mice. Where depicted, either the Fgf15 or hsp68 promoters were used in the assay. Solid lines represent genomic fragments used in the reporter constructs, whereas dashed lines correspond to deleted genomic fragments. To the right of the constructs are the results of the transgene expression analysis indicating the number of transgenic embryos that stained in a Fgf15-like pattern versus the total number of transgenic embryos. Sites of expression at E9.5 are indicated. op, optic vesicle; hb, hindbrain (except for r1); sc, spinal cord; pmb/r1, posterior midbrain/ rhombomere1; ph, pharyngeal epithelia. diencephalon, a weak lacZ expression was found (Fig. 2B ), but we thought that it was not a significant enhancer because its expression was very weak and variable. Therefore the 12 kb flanking region does not contain entire enhancers to reproduce completely endogenous Fgf15 expression. Within the region where lacZ was expressed, lacZ showed a similar expression pattern to endogenous Fgf15, except that lacZ activity was also detected in the ventral part of the hindbrain and cervical spinal cord ( Fig. 2A-A 00 and B-B 00 ). The expression in pharyngeal ectoderm appeared to be a perdurance of lacZ activity rather than ectopic expression because Fgf15 is expressed in pharyngeal ectoderm shortly before this stage (Wright et al., 2004; Vincentz et al., 2005) . When tested the 6.5 kb 5 0 -flanking region (Fig. 1, RC3 ), lacZ expression in the pmb/r1 and pharyngeal epithelia was disappeared (Fig. 2C ), suggesting that a 1.5 kb HindIII-EcoRI fragment (purple in Fig. 1 ) has enhancer activities in the pmb/r1 and pharyngeal epithelia. Actually a reporter construct, in which the 1.5 kb HindIIIEcoRI fragment was directly fused to 0.9 kb Fgf15 promoter (Fig. 1, RC4 ), showed enhancer activities in the pmb/r1 and pharyngeal epithelia similarly to RC1 and 2 (Fig. 2D) , indicating that the 1.5 kb HindIII-EcoRI fragment is sufficient for expression in the pmb/r1 and pharyngeal epithelia (designated as pmb/r1/ph enhancer). This result completely agrees with a recent report in which a 4.2-kb enhancer fragment located 4 kb upstream from the transcription start site of the Fgf15 gene, that contains the 1.5 kb HindIIIEcoRI fragment, can drive the expression of a lacZ reporter in the r1 and pharyngeal ectoderm and endoderm in transgenic embryos as early as E9.0 (Zhang et al., 2005) . It was noteworthy that there is a narrow gap in the midbrain/r1 boundary, the isthmus, similarly to Fgf15 expression ( Fig. 2A and D, arrow) . A 3.6 and 1.4 kb 5 0 -flanking region (Fig. 1, RC5 and 6, respectively) showed a similar lacZ expression to that of RC3 Fig. 2 . Comparison of the sites of expression of Fgf15 reporter constructs in transgenic embryos to Fgf15 mRNA. Whole-mount in situ hybridization of embryos with a Fgf15 riboprobe (A) compared to transgenic embryos carrying reporter constructs (from Fig. 1 ) and stained for b-galactosidase activity at E9.5 (B-F). (A) Fgf15 expression was observed in the optic vesicle, midbrain, hind brain, dorsal spinal cord, tail bud, and pharyngeal arches from arch II to presumptive arch IV. Its expression was also seen at the diencephalon and prosencephalic commissural plate. An arrow indicates the midbrain-hindbrain boundary, isthmus, in which Fgf15 expression was absent. (A 0 and A 00 ) A transverse section taken at the level of otic vesicle indicated by the bar in (A). Fgf15 expression was observed at pharyngeal endoderm (A 0 ) and was localized to the dorsal parts of the neural tube (A 00 ). I, pharyngeal arch I; II, pharyngeal arch II; end, pharyngeal endoderm; ect, pharyngeal ectoderm. (B) Robust lacZ expression of RC2 was observed in the optic vesicle, hindbrain, dorsal spinal cord, pharyngeal epithelia from arch II to presumptive arch IV, and weak expression was seen in the midbrain. There was a weak ectopic expression in the ventral hindbrain and cervical spinal cord in RC1-8 except for RC4. (B 0 and B 00 ) A transverse section taken at the level of otic vesicle indicated by the bar in (B). LacZ expression was observed at pharyngeal endoderm (B 0 ) and the dorsal parts of the neural tube (B 00 ) similarly to (A 0 and A 00 ). LacZ expression was also observed in pharyngeal ectoderm (B 0 ), which appeared to be a perdurance of lacZ activity (see text). (C) RC3 showed enhancer activities in the optic vesicle, hindbrain (except for r1), and dorsal spinal cord, and not in the pmb/r1 and pharyngeal epithelia. (D) RC4 expression revealing the pmb/r1 and pharyngeal epithelia enhancer activity. Note that lacZ expression in the pmb/r1 is absent in the isthmus, similarly to Fgf15 expression (arrow). (E and F) RC6 and 8 showed similar enhancer activities, revealing that a 540 bp SphI-EcoRI fragment is an enhancer of the optic vesicle, hindbrain (except for r1), and dorsal spinal cord.
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( Fig. 2E and data not shown), while 0.9 kb 5 0 -flanking region had no enhancer activities ( Fig. 1, RC7 ), suggests that a 540 bp SphI-EcoRI fragment (green in Fig. 1 ) has enhancer activities in the optic vesicle, hindbrain (except for r1) and dorsal spinal cord. When enhancer activities of the 540 bp SphI-EcoRI fragment were tested with the hsp68 promoter (Fig. 1, RC8 ), lacZ showed a similar expression pattern to that of RC6 ( Fig. 2E and F) . These data clearly showed that the 540 bp SphI-EcoRI fragment includes an enhancer of the optic vesicle, hindbrain (except for r1) and dorsal spinal cord (designated as op/hb/sc enhancer).
Hindbrain/spinal cord and pmb/r1/ph enhancers are conserved between humans and mice
Recent comparative genomics studies have identified a lot of enhancers conserved among multiple species (Ahituv et al., 2004; Blanchette et al., 2004) . To test whether the mouse Fgf15 enhancers are conserved among multiple species, we used the Vertebrate Multiz Alignment and Conservation section of the UCSC genome bioinformatics web site (http://genome.ucsc.edu/) to search sequence similarities of genomes among multiple species. Actually there are conserved sequences within the two Fgf15 enhancers described above (Fig. 3) . These sequences are conserved among mice, rats, humans, dogs, and cows, but not in chicks, suggesting that these two enhancers are only conserved among mammals (Fig. 3 , data not shown). This result is consistent with the fact that the chick Fgf19 is not expressed in the hindbrain and spinal cord like Fgf15 in mice (McWhirter et al., 1997; Kurose et al., 2004; Wright et al., 2004) . In order to demonstrate that the conserved sequences are essential for enhancer activities, we further dissected the op/hb/sc (540 bp SphI-EcoRI) and pmb/r1/ ph (1.5 kb HindIII-EcoRI) enhancers.
Within the op/hb/sc (540 bp SphI-EcoRI) enhancer, a major block of conserved sequences lies between KpnI and BglII sites (Fig. 3A) . Actually a 5 0 -60 bp deletion of this enhancer did not cause any changes of lacZ expression pattern (Fig. 3A, RC9 ). In contrast, any deletions of a KpnI-BglII fragment resulted in loss of enhancer activities (Fig. 3A, RC10 and 11), indicating that this conserved sequences are essential for enhancer activities. When tested a 350 bp SphI-BglII fragment of this enhancer with 0.9 kb Fgf15 promoter, lacZ expression was observed in the hindbrain/spinal cord, but not in the optic vesicle ( Fig. 3A,  RC12; Fig. 4B ). We further checked this enhancer activity at different stages, and found that the hindbrain/spinal cord enhancer was active at least between E8.5 and E12.5 ( Fig. 4A-C) . Notably, the corresponding region of the human FGF19 genome showed similar enhancer activities in the hindbrain/spinal cord in transgenic mouse embryos at E8.5 and E9.5 (Fig. 3A, RC13, 3C ; Fig. 4D and E). Although human FGF19 enhancer occasionally directed lacZ expression in the diencephalic roof plate and the ectoderm surrounding the optic vesicle ( Fig. 4D and E) , the similar enhancer activities in the hindbrain/spinal cord indicate that this enhancer is conserved between humans and mice.
Within the pmb/r1/ph (1.5 kb HindIII-EcoRI) enhancer, a major block of conserved sequences lies in 5 0 -half of this enhancer (Fig. 3B) . In order to demonstrate that this conserved sequences are sufficient for enhancer activities, we cloned the conserved sequences from both mouse and human genomes by PCR and checked enhancer activities (Fig. 3B, RC14 and 15, respectively; 3D). RC14 showed identical lacZ expression to that of RC4, indicating that the 700 bp conserved sequence is sufficient for its enhancer activities (Fig. 4F) . This pmb/r1/ph enhancer activity was observed at E9.5 and E10.5 ( Fig. 4F and G) , during the period that Fgf15 expression in the pharyngeal epithelia was observed (Wright et al., 2004; Vincentz et al., 2005) . Moreover, lacZ expression in the pmb/r1 was maintained at E12.5 (Fig. 4H) . Interestingly, RC15, a 750 bp corresponding human genome, showed a similar lacZ expression in the pharyngeal epithelia and the pmb/r1 at E9.5 and E10.5 though the isthmus was stained as well ( Fig. 4I  and J) . While a slight difference exists in the pmb/r1 expression, the overall similarity of lacZ expression patterns between RC14 and 15 strongly suggests that this enhancer is conserved between humans and mice.
2.3. The conserved posterior midbrain/rhombomere1 enhancers show similar enhancer activities in chick embryos and are controlled by Fgf8 signal
The part of r1 differentiates into cerebellum and its development is controlled by a strong Fgf signal mediated by Fgf8b (Chi et al., 2003; Sato et al., 2004; Nakamura et al., 2005) . LacZ expression in the r1 of RC14 and 15 raised a possibility that this enhancer is controlled by Fgf8 signal. It has been reported that Fgf8 positively regulated Fgf15 expression in the anterior neural ridge of the forebrain (Echevarria et al., 2003) . To test whether this enhancer is also controlled by Fgf8 signal in a different context, we examined the enhancer activities in the developing brain by utilizing chick in ovo electroporation which enables both enhancer analysis and gain-of-function experiments at specific developmental stages (Funahashi et al., 1999; Uchikawa et al., 2003; Nakamura et al., 2004) . Interestingly, the mouse pmb/r1/ph enhancer (RC14) drove lacZ expression in the pmb/r1 in chick embryos in almost the same way as in mouse embryos ( Fig. 5A and E, n = 7), suggesting that regulators of this enhancer are probably conserved between mice and chicks. LacZ expression in the r1 was more intense than that in the posterior Fig. 4 . Hindbrain/spinal cord, and posterior midbrain/rhombomere1 and pharyngeal epithelia enhancers are conserved between humans and mice. The number of transgenic embryos that stained in a Fgf15-like pattern versus the total number of transgenic embryos are indicated in each panels. (A-C) RC12 directed lacZ expression in the hindbrain/spinal cord at E8.5 (A), E9.5 (B), and E12.5 (C). (E and F) RC13 directed lacZ expression in the hindbrain/spinal cord in a similar fashion to RC12 (compare A with D, B with E). LacZ expression was also observed in the diencephalic roof plate and the ectoderm surrounding the optic vesicle (D and E). (F-H) RC14 showed enhancer activities in the pmb/r1 and pharyngeal epithelia (red arrows) at E9.5 (F), E10.5 (G), and E12.5 (H). The isthmus is indicated by a black arrow. (I and J) RC15 directed lacZ expression in the pmb/r1 and pharyngeal epithelia (red arrows) similarly to RC14 (compare F with J, G with J). The scattered ectopic lacZ expression in the ventral neural tube (F and I) may be due to hsp68 promoter activities. -D) show expression of co-electroporated nonspecific EGFP gene, confirming a gene transfer area in the embryo. LacZ staining (E-H) reveals enhancer activity. Both mouse and human pmb/r1 enhancer showed enhancer activities in the pmb/r1 in a highly similar way to those in transgenic mouse embryos (E and G). With co-electroporation of Fgf8b expression vector, the domain of lacZ expression markedly expanded (F and H), being accompanied by the morphological change that implies the fate change of the midbrain to the cerebellum. midbrain similarly to transgenic mice. Because a strong Fgf signal mediated by Fgf8b is sufficient to induce cerebellar development and a lower level of the signaling transduced by Fgf8a, Fgf17, and Fgf18 induce midbrain development (Liu et al., 2003; Sato et al., 2004) , this result again implies that the mouse pmb/r1/ph enhancer is controlled by Fgf8 signal. Actually, co-electroporation of Fgf8b expression vector resulted in expansion of lacZ expression (Fig. 5B and F, n = 6). This change seemed to be accompanied by the fate change of the midbrain to the cerebellum (Liu et al., 1999; Sato et al., 2001; Liu et al., 2003) . Interestingly, the human pmb/r1/ph enhancer (RC15) also showed enhancer activities in chick embryos similarly to those in mouse embryos (Fig. 5C and G, n = 7), and lacZ expression was markedly expanded by Fgf8b over-expression ( Fig. 5D and H, n = 4). These data clearly indicate that the mouse and human pmb/r1/ph enhancers are positively regulated by Fgf8 signal.
Mouse Fgf15 can induce Fgf8 in the rhombomere1
Fgf8 has been shown to have organizer activities in the isthmus region (Chi et al., 2003; Sato et al., 2004; Nakamura et al., 2005) . The presumptive isthmus is determined by the repressive interaction between Otx2 and Gbx2 (Joyner et al., 2000; Simeone, 2000) and Fgf8, Pax2/5, and En1/2 were shown to be in a positive feedback loop for their expression (Nakamura et al., 2005) . In order to test whether there is also a positive feedback loop between Fgf15 and Fgf8, we over-expressed Fgf15 in the midbrain and hindbrain (Fig. 6A and C) . Interestingly Fgf15 can induce Fgf8 expression in the r1 (4/8, Fig. 6B and D) , suggesting that Fgf15 expressed in the r1 positively regulates Fgf8 expression in the isthmus. Together with enhancer analyses, these findings suggest that reciprocal positive regulation exists between Fgf15 and Fgf8 in the isthmus/r1 region.
Discussion
In the present study, we identified two Fgf15 enhancer regions which are evolutionally conserved among mammalian species. We demonstrated that the enhancer activities are conserved between humans and mice by utilizing transgenic mouse embryos and in ovo electroporation in chick embryos. Not only that the enhancers of both humans and mice showed enhancer activities in the transgenic mouse embryos, but these enhancers showed enhancer activities in chick embryos in a similar way to those in transgenic mouse embryos. These data indicate that upstream regulators of these enhancers are in common between mouse and chick embryos, and that the difference in mouse Fgf15 and chicken Fgf19 expression patterns (McWhirter et al., 1997; Kurose et al., 2004 ) is due to the difference in their cis-regulatory elements, which is supported by the information of the UCSC genome bioinformatics (Blanchette et al., 2004) . Because the amino acid sequences of human FGF19 are more similar to those of chicken FGF19 (63% identity) than to mouse FGF15 (51% identity) (Nishimura et al., 1999; Ladher et al., 2000) , it seems paradoxical that these two enhancers are conserved between humans and mice, but not between humans and chicks. In the case of Fgf15 (Fgf19), the degree of sequence similarities of amino acids does not correlate with the conservation of the cis-regulatory elements and evolutional distance. Thus, our data are consistent with the recent idea that the evolution of diversity is directly related to the evolution of genetic regulatory programs (Carroll et al., 2001 ).
Mouse Fgf15 and human FGF19 may play a role in the early development of the neural crest cells
Fgf15 is the first Fgf found to be expressed in the spinal cord during early neural development in mice (McWhirter et al., 1997) . It is likely that Fgf15 expressing cells in the dorsal neural tube include premigratory neural crest precursors, suggesting that Fgf15 may play a role in the early development of these cells. In the present study, we showed that enhancer activities of the hindbrain/spinal cord are conserved between humans and mice at E8.5 and E9.5. Because most of cardiac neural crest cells enter pharyngeal arches and start to migrate to the cardiac outflow tract by Fig. 6 . Fgf15 can induce Fgf8 in the rhombomere1. Lateral views (A and C) and dorsal views (B and D) of chick embryos. pCIG-Fgf15 was electroporated into the cranial neural tube of stage 9-10 chick embryos and its expression was monitored by GFP fluorescence after 48 h incubation (A and C). The upper panels show the embryo electroporated to the right side and the lower panels the embryo electroporated to the left side. In both cases, Fgf8 expression was expanded to the r1 (B and D, red arrowheads). Isthmus was indicated by a broken line (A and C) and an arrow (B and D). r1 was indicated by a bracket (B and D) . EP, electroporation side; Cont, control side. E10.5 (Jiang et al., 2000; Gitler et al., 2003; Stoller and Epstein, 2005) , these data suggest that both mouse and human hindbrain/spinal cord enhancer exerts its activity during critical period of early development of the cardiac neural crest cells. In addition, when Cre-expressing transgenic mice, which includes the Fgf15 hindbrain/spinal cord enhancer, was intercrossed with the ROSA26 Cre reporter line (Soriano, 1999) to trace cell lineage by lacZ expression, progeny of Fgf15-expressing cells contributed to the formation of neural crest cell-derived tissues such as dorsal root ganglion and cardiac outflow tract (H.S., unpublished observation). Thus, our data suggest that both mouse Fgf15 and human FGF19 may play a role in the early development of the cardiac and trunk neural crest cells, which emerge from the hindbrain and spinal cord (Le Douarin et al., 2004; Martinsen, 2005) .
Fgf15 may be involved in the development of the cerebellum in collaboration with Fgf8
Fgf17 and Fgf18 are also expressed in the isthmic region and Fgf8 regulates their expression. It is believed that Fgf8 collaborates with both Fgf17 and Fgf18 to organize the midbrain and cerebellum . Here, we showed that a reciprocal positive regulation exits between Fgf15 and Fgf8 in the isthmus and r1. Most recently, Zhang et al. showed that Fgf15-Cre mice, which contain the pmb/r1 and pharyngeal epithelia enhancer, exhibit their enhancer activities as early as E9.0 (Zhang et al., 2005) . Both Fgf15 and Fgf8 begin to be expressed in the isthmus/r1 at E8.5 (McWhirter et al., 1997; Ishibashi and McMahon, 2002) , shortly before the pmb/r1 enhancer activities are detected. Thus, it seems that the reciprocal positive regulation between Fgf15 and Fgf8 may be involved in the maintenance of their expression after E9.0 rather than their induction in the isthmus/r1. Although any abnormal phenotype in the cerebellum has not been reported in Fgf15 mutants probably due to their mid-gestation to postnatal lethality (Wright et al., 2004; Vincentz et al., 2005) , it is possible that Fgf8 collaborates with Fgf15 to organize the cerebellum. It would be interesting to determine whether Fgf8 expression in the isthmus is affected in the Fgf15 mutant mice.
3.3. Human FGF19 may be a candidate gene for congenital heart defects Congenital heart defects represent a frequently occurring and potentially lethal class of birth defects that affects roughly 1% of live human newborns (Hoffman and Kaplan, 2002) . It is believed that complex tissue-tissue interactions between the secondary heart field, the pharyngeal epithelia and the cardiac neural crests are crucial for the outflow tract and aortic arch to develop properly (Hutson and Kirby, 2003) . Cardiac neural crests emerge from the dorsal neural tube between the midotic placode and the caudal limit of somite 3 (Kirby et al., 1983; Martinsen, 2005) . Therefore, it appears that Fgf15 expressed in the hindbrain/spinal cord and in pharyngeal epithelia plays a role in early development and behavior of cardiac neural crests. Actually, homozygous Fgf15 mutants present heart defects primarily caused by a failure of cardiac outflow tract alignment . Detailed examination revealed that although the amount of migrating cardiac neural crest appears unchanged, the cardiac neural crest cell behavior was affected in Fgf15 mutants. The aberrant cardiac neural crest cell behavior causes failures of the alignment of the conotruncal cushions and of cardiac neural crest migration to the proximal outflow tract, leading to overriding aorta and ventricular septal defects . In the present study, we have shown that both the enhancer of hindbrain/spinal cord and the pharyngeal epithelia enhancer are conserved between humans and mice. Thus, together with cardiac outflow tract defects in the Fgf15 mutants, these data strongly suggest that human FGF19 is involved in control of cardiac neural crest cell behavior and is a candidate gene for the congenital heart defects in humans. Moreover, our data indicate that both the two human FGF19 enhancers in this study can be targets in human molecular epidemiologic studies, in addition to the coding region of the human Fgf19 gene.
Considering the pathogenesis of cardiac defects in Fgf15 mutants, it is interesting to note the present data that Fgf15 is in reciprocal positive regulation with Fgf8 in the pmb/r1. Because the enhancer of the pmb/r1 simultaneously controls the expression in pharyngeal epithelia, there is a possibility that Fgf15 may interact with Fgf8 in pharyngeal arches. Both Fgf15 and Fgf8 are expressed in developing pharyngeal epithelia in an almost complementary manner, which is similar to that Fgf8 expression in the ishtmus is flanked by Fgf15 in the pmb and r1 in mouse embryos Vincentz et al., 2005) . It would be interesting to determine whether Fgf8 expression in pharyngeal epithelia is affected in the Fgf15 mutant mice.
Concluding remarks
The present study has shown that two enhancers are conserved among mammals; one is in the hindbrain/spinal cord, and the other in the pmb/r1 and pharyngeal epithelia. We also show that the pmb/r1 enhancer is controlled by Fgf8 signal and in turn Fgf15 induce Fgf8 expression in the r1, suggesting that reciprocal positive regulation exists between Fgf15 and Fgf8. These findings, together with cardiac outflow tract defects in the Fgf15 mutants, suggest that human FGF19 is involved in early development and behavior of the cardiac neural crest cells possibly by collaboration with Fgf8 signal. Human FGF19 may be a candidate gene for some congenital heart defects in humans and the Fgf15 mutant mouse is a useful animal model for elucidating the pathogenesis of congenital heart defects.
Material and methods

Generation of reporter constructs
Isolation of genomic DNA including the Fgf15 locus was previously described (Saitsu et al., 2005) . Genomic DNA of the Humam FGF19 locus was cloned by PCR using a Human BAC clone RP11-124K14, which was obtained from BACPAC Resources Center (BPRC), as a template. Reporter constructs were generated by subcloning DNA restriction fragments or PCR fragments from the genomic DNA into the hsp68 promoter-lacZ-poly(A) cassette (ASShsplacZpA vector) (Sasaki and Hogan, 1996) . The restriction sites listed on reporter constructs 1 through 12 (Figs. 1 and 3A and B) correspond to those used in subcloning. Genomic fragments containing 0.9 kb EcoRI-XhoI Fgf15 promoter (RC1-7, 9-13) were fused to this cassette by replacing hsp68 promoter. RC4 was constructed by removing 5.6 kb EcoRI fragment from RC2. RC12 was constructed by inserting 350 bp SphI-BglII blunted fragment into AscI blunted site of RC7. RC13-15 were constructed by inserting PCR fragments into AscI blunted site of RC7 (RC13) or upstream SmaI site of Asshsp68LacZpA vector (RC14, 15). Primers were listed below: (RC13) forward 5
0 . The sequencing of all PCR fragments was performed by dye terminator cycle sequencing (PE Applied Biosystems) using an ABI Prism 310 DNA sequencer. For enhancer analysis in chick embryos, a PCR fragment used in RC15 was inserted into upstream SmaI site of ptkLacZ, in which EGFP gene of the ptkEGFP vector (Uchikawa et al., 2003) was replaced with LacZ gene.
Production of transient transgenic embryos
B6C3F1 (C57BL/6 · C3H) mice were used to produce transgenic embryos as previously described (Hogan et al., 1994) . The restriction endonuclease, NotI or SalI, was used to separate the transgene from the vector sequences prior to microinjection. Transgenes were purified by using QIAquick Gel Extraction kit (QIAGEN). The genotype of embryos was determined by PCR amplification of a lacZ sequence from genomic DNA extracted from extra embryonic tissues. Primers, forward 5 0 -ACT ATCCCGACCGCCTTACT-3 0 , reverse 5 0 -TAGCGGCTGATGTTGAA CTG-3 0 , were used under the following PCR conditions: 95°C for 45 s, 62°C for 30 s, 72°C for 30 s, for 25 rounds followed by a final extension at 72°C for 2 min. For staging embryos, the day of vaginal plug detection was designated as E0.5. Transient transgenic embryos were dissected at E8.5, E9.5, E10.5, and E12.5, and processed for b-galactosidase staining.
Whole-mount b-galactosidase staining and RNA in situ hybridization
Detection of b-galactosidase activity in dissected embryos was performed as previously described (Hogan et al., 1994) . The stained embryos were photographed in 80% glycerol in PBS with a Keyence VB-G25 microscope. Whole-mount RNA in situ hybridization of embryos was performed as previously described (Parr et al., 1993) . Digoxigenin (DIG) probes were synthesized using the DIG RNA labeling Kit (Roche). The probes used in this study were as follows: mouse Fgf15 (Ishibashi and McMahon, 2002) , chick Fgf8 (Sato et al., 2001) . The embryos were sectioned at thickness of 20 lm to analyze the detailed staining patterns. Photographs of the sections were taken on a Zeiss Axiophot2 microscope.
Generation of expression vectors
Mouse Fgf8b cDNA (Crossley and Martin, 1995) were inserted into expression vector pCIR (kindly provided by Dr. Megason). This base vector contains a constitutive promoter, multiple cloning sites, and an internal ribosomal entry signal (IRES) that is followed by a cDNA encoding DsRed. pCIG-Fgf15 expression vector was described previously (Ishibashi and McMahon, 2002) . EGFP gene was subcloned into the pCIR, producing pCIR-EGFP expression vector.
In ovo electroporation
In ovo electroporation was carried out as previously described (Funahashi et al., 1999) . Briefly, fertile chicken eggs obtained from a local farm were incubated at 39°C. Plasmid solution was injected into the cranial neural tube of Hamburger-Hamilton stage (Hamburger and Hamilton, 1992) 10-12 (for enhancer analysis) and stage 9-10 (for Fgf15 over-expression analysis) chicken embryos, respectively, with 0.2% Fast Green. Electrodes were placed on the vitelline membrane at a distance of 4 mm apart, then rectangular pulses (30 V, 50 ms, five times) were given by a CUY21EDIT electroporator (NEPA GENE). Since, DNA is negatively charged, only the anode side of the neural tube is transfected. The other side is used as a control. For enhancer analysis, a DNA solution containing the reporter vector (a final concentration of 0.5 lg/ll), the pCIR or pCIR-Fgf8b vector (1.0 lg/ll) and the marker vector (pCIR-EGFP, 0.3 lg/ll) was injected. For mouse Fgf15 over-expression analysis, pCIG-Fgf15 (2.7 lg/ll) was injected, and electroporation was done as same as above. The eggs were sealed and allowed to develop for a further 24 (enhancer analysis) or 48 h (over-expression analysis). Embryos with high levels of GFP fluorescence in the neural tube were processed for further analysis.
Bioinformatics
We used an UCSC genome bioinformatics web site (http:// genome.ucsc.edu/) to search sequence similarities of genomes among multiple species. The sequence similarities between humans and mice are searched by utilizing CLUSTALW web site (http://align.genome.jp/).
